Company intelligence / Profile preview

InDevR

Boulder, Colorado, United Statesindevr.com ↗

Ownership: Private
Employees: ~25
Development stage: Commercial

Overview

InDevR provides advanced multiplexed immunoassay platforms such as VaxArray and CypherOne that accelerate vaccine development by enabling rapid, high-throughput analysis of antigens, antibodies, mRNA constructs, polysaccharides, conjugates, and viral vectors. Their technologies support R&D through GMP release testing stages with regulatory-compliant software. The company is recognized globally for its contributions to standardization in vaccine analytics.

Modalities: DeviceDiagnostic equipmentMicroarray detection technology
Industry: Molecular Diagnostics

Partnerships

Aldevron

Beyond the preview

Go deeper on InDevR.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on InDevR.

Explore the full profile